Cotellic Prices, Coupons, Copay Cards & Patient Assistance
Cotellic (cobimetinib) is a member of the multikinase inhibitors drug class and is commonly used for Histiocytic Neoplasm, and Melanoma - Metastatic.
Cotellic is available as a brand name drug only, a generic version is not yet available. View generic Cotellic availability for more details.
Cotellic prices
Oral Tablet
20 mg Cotellic oral tablet from $7,973.01 for 63 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 63 | $126.56 | $7,973.01 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Cotellic Coupons, Copay Cards and Rebates
Cotellic offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Cotellic Genentech Oncology Co-pay Assistance Program
Eligible commercially insured patients may pay $0 in out-of-pocket costs for the prescribed product
- Applies to:
- Cotellic
- Number of uses:
- Per prescription per calendar year
Form more information phone: 855-692-6729 or Visit website
Cotellic Genentech Oncology Co-pay Assistance Program Rebate
Eligible commercially insured patients enrolled in the program may be entitled to a rebate for their out-of-pocket cost if they paid the provider directly for treatment.
- Applies to:
- Cotellic
- Number of uses:
- One rebate per prescription fill
Form more information phone: 855-692-6729 or Visit website
Patient Assistance & Copay Programs for Cotellic
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Cotellic (cobimetinib) Tablet
More information please phone: 866-316-7263 Visit website
Provider: Genentech Oncology Access Solutions
Eligibility requirements:- Determined case by case
- Based on FPL
- Varies
- Must be treated by US licensed healthcare provider
- Call for most recent medications as the list is subject to change. Eligibility determined on a case-by-case basis. Contact program for details.
- Cotellic (cobimetinib) Tablet
More information please phone: 888-249-4918 or 866-422-2377 Visit website
Provider: Genentech Patient Foundation
Eligibility requirements:- Uninsured or Underinsured with no prescription coverage for needed medication
- Based on FPL
- Medically appropriate condition/diagnosis
- Must be treated by US licensed healthcare provider
- The Genentech Access to Care Foundation is now the Genentech Patient Foundation. Eligibility determined on a case-by-case basis. Call for most recent medications as the list is subject to change. This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
- Cotellic (cobimetinib) Tablet
More information please phone: 888-941-3331 or 866-422-2377 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Alecensa
Alecensa (alectinib) is an oral kinase inhibitor that may be used to treat certain types of ...
Alunbrig
Alunbrig (brigatinib) is used to treat anaplastic lymphoma kinase-positive (ALK+) metastatic ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Augtyro
Augtyro (repotrectinib) is a next-generation TKI (Tyrosine Kinase Inhibitor) cancer medicine used ...
Ayvakit
Ayvakit (avapritinib) is a prescription medicine used for the treatment of gastrointestinal stromal ...
Balversa
Balversa (erdafitinib) is an oral kinase inhibitor that may be used to treat adults with locally ...
Braftovi
Braftovi is a targeted cancer treatment used in combination with Mektovi, mFOLFOX6, or Erbitux, to ...
Cabometyx
Cabometyx is used to treat advanced kidney cancer, liver cancer, thyroid cancer, and pancreatic and ...
Caprelsa
Caprelsa (vandetanib) is used to treat thyroid cancer that cannot be removed by surgery or that has ...
More about Cotellic (cobimetinib)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español